Clinical Trial Update: Study of A3309 in Patients With Dyslipidemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for A3309 in patients with dyslipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• A3309

Snippet

Sponsor: Albireo | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED